Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03274830Active Not Recruiting

A Post Market Clinical Follow-up Study With the aneXys Cup

Role: lead

NCT04598568Completed

Post-market Clinical Follow-up on the balanSys UNI Knee Prosthesis Implanted With a Spacer Block Surgical Technique

Role: lead

NCT03047564Not ApplicableCompleted

Metal Ion Concentration Between Coated and Uncoated TKA

Role: collaborator

NCT04322916Unknown

Clinical Study With the RM Pressfit Vitamys Cup in Combination With a Mathys Stem

Role: lead

NCT03032133Not ApplicableCompleted

Pain Control After Total Knee Arthroplasty

Role: collaborator

NCT02203214Completed

Induced ACL Healing With the Ligamys Technique: a Prospective, Multicenter Observational Case Series

Role: lead

All 6 trials loaded